Pharmaceutical Continuous Manufacturing Market

Pharmaceutical Continuous Manufacturing Market (Application - Active Pharmaceutical Ingredient, Biologics, and Dry Powders; End Users - Pharmaceutical Companies and Contract Manufacturing Organization) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Pharmaceutical Continuous Manufacturing Technology Market: Snapshot

In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This in turn serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption.

Other advantages of pharmaceutical continuous manufacturing technology is the superior development speeds, higher process safety when employing hazardous chemistries, and the opportunity to perform reactions that cannot be run under batch processing.

A study by Transparency Market Research forecasts the global pharmaceutical continuous manufacturing technology market to expand at a healthy CAGR of 8.8% from 2017 to 2025. Expanding at this pace, the market which was worth US$1.74 bn in 2016 is expected to attain a value of US$3.693 bn in 2025.

pharmaceutical continuous manufacturing technology market

Contract Manufacturing Organizations in Asia Pacific to Drive Market

Some of the key application segments of the global pharmaceutical continuous manufacturing technology market are biologics, dry powders, active pharmaceutical ingredients, etc. Of them, the segment of biologics accounts for a dominant position in the market. It held a share of about 35.3% in the global market in 2016. It was trailed by active pharmaceutical ingredient.

Application-wise, the global pharmaceutical continuous manufacturing technology market can be divided into contract manufacturing organizations, pharmaceutical companies, etc. Currently, pharmaceutical companies lead the market with maximum demand and are trailed by contract manufacturing organizations. In the near future, the contract manufacturing organizations in Asia Pacific region are predicted to fuel market growth majorly. Along with increasing awareness about the technology, various initiatives by FDA are also egging manufacturers to shift to continuous manufacturing over batch manufacturing process.

Demand for Better Technology Propels Europe Market to Fore

From a geographical standpoint, currently Europe dominates the global pharmaceutical continuous manufacturing technology market. Strong demand for advanced technology from pharmaceutical companies and presence of many contract manufacturing entities has majorly fuelled the market in the region. The growth in Europe is primarily powered by the U.K. and Germany. The region’s leading share in 2016 came to around 35%. The market in the region is also expected to outshine others in terms of growth by registering a CAGR of 9.6% in the forecast period. Expanding at this pace, it is predicted to clock a revenue of US$1.38 bn by 2025. This is mainly on account of the early availability of advanced technologies and greater number of technology providers across the region.

Asia Pacific trails Europe vis-à-vis market share. In 2016, the region held a share of about 34% in the global pharmaceutical continuous manufacturing market. The growth in Asia Pacific has been mainly driven by China and India, which are home to numerous contract manufacturing organizations. China is considered a highly promising market because of increasing acceptability of technologically advanced continuous manufacturing and growing awareness about the advantages of the technology.

North America comes in the third position in terms of market size. Initiatives by FDA to switch from current batch process to continuous manufacturing technology drives interest among the pharmaceutical companies. 

Some of the prominent participants in the global pharmaceutical continuous manufacturing technology market are Siemens AG, GEA group, Continuus Pharmaceutical, S K Biotek ltd, Korsch AG, Scott Equipment Company, Corning Life Sciences, and Chemtrix.

Heavy Advantages of Continuous Process Manufacturing to Boost Pharmaceutical Continuous Manufacturing Market

Continuous manufacturing is a high level manufacturing approach with the possibility to improve quality and consistency of drugs with lower cost. This creation line is worked in a continuous stream, with start to finish incorporation of manufacturing measures. The pharmaceutical continuous manufacturing market is required to observe critical development during the conjecture time frame, because of innovative progressions in continuous manufacturing frameworks and backing by the administrative experts for selection of continuous manufacturing frameworks. Nonetheless, greater expense of pharmaceutical continuous manufacturing frameworks obstructs the pharmaceutical continuous manufacturing market development.

Asia-Pacific is expected to rise remarkably in the coming years because of expansion in mindfulness about cutting edge pharmaceutical continuous manufacturing frameworks, rise number of pharmaceutical organizations, and expansion sought after for continuous manufacturing frameworks. Notwithstanding, greater expense of pharmaceutical continuous manufacturing frameworks may hamper the market development in Asia-Pacific.

Manufacturing innovation gives a superior method of manufacturing drug items that save time, improve quality, lessen required creation and use of creation limit in continuous manufacturing are excepted to be significant drivers of the worldwide pharmaceutical continuous manufacturing market. In any case, the high execution cost of computerized units for continuous manufacturing is restriction in market development. Also, the business the scholarly world coordinated efforts, development in nonexclusive manufacturing are making beneficial and joint endeavors among the main entertainer are the significant chances in the worldwide market.

Continuous manufacturing measure can accelerate the manufacturing cycle and improve wellbeing while at the same time utilizing perilous synthetic and lead hazardous interaction. It improves proficiency of the pharmaceutical manufacturing are boosting reception of the pharmaceutical continuous manufacturing measure across various organizations which is driving development of the worldwide pharmaceutical continuous manufacturing market.

Regardless of these development prospects, the absence of specialized and administrative clearness are restricting selection of the pharmaceutical continuous manufacturing measure which is hampering development of the worldwide pharmaceutical continuous manufacturing market. Furthermore, continuous cycle is required to have development prospect attributable to the developing of blend of complex innovations prompting precise observing, computerization, better gear, and programming.

The global pharmaceutical continuous manufacturing technology market is segmented as follows:

by Application Type

  • Active Pharmaceutical ingredient
  • Biologics
  • Dry Powders
  • Others

by End-users

  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

    1. Preface 
          1.1. Report Scope and Market Segmentation 
          1.2. Research Highlights

    2. Assumptions and Research Methodology 
          2.1. Assumptions
          2.2. Acronyms Used
          2.3. Research Methodology

    3. Executive Summary
          3.1. Global Pharmaceutical Continuous Manufacturing Technology Market Snapshot

    4. Market Overview
          4.1. Product Overview
          4.2. Market Opportunity Map 
          4.3. Key Industry Events
          4.4. Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, 2015–2025
          4.5. Global Pharmaceutical Continuous Manufacturing Technology Market Outlook
          4.6. Porter’s Five Forces Analysis 

    5. Market Dynamics
          5.1. Drivers and Restraints Snapshot Analysis 
          5.2. Drivers
                  5.2.1. Increased inefficiency in the manufacturing process
                  5.2.2. Safer production
                  5.2.3. Advantages over the batch manufacturing
                  5.2.4. Increased FDA initiatives 
          5.3. Restraints
                  5.3.1. Regulatory challenges
                  5.3.2. Difficulties in adoption
          5.4. Opportunities
                  5.4.1. Improving Pharma Infrastructure
          5.5. Global API Manufacturing Technology Suppliers Market Share Analysis, by Company, 2016 (estimated) 

    6. Global Pharmaceutical Continuous Manufacturing Technology Market, by Application
          6.1. Introduction
          6.2. Key Findings 
          6.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
          6.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
          6.5. Global Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
          6.6. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Application
          6.7. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application
          6.8. Key Trends

    7. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user
          7.1. Introduction 
          7.2. Key Findings 
          7.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
          7.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
          7.5. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user 
          7.6. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user
          7.7. Key Trends

    8. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Region
          8.1. Global Market Scenario, by Country
          8.2. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Region 
          8.3. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Region, 2015–2025 
          8.4. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Region 

    9. North America Pharmaceutical Continuous Manufacturing Technology Market Analysis
          9.1. Key Findings
          9.2. North America Pharmaceutical Continuous Manufacturing Technology Market Overview
          9.3. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
          9.4. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
          9.5. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
          9.6. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
          9.7. North America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
          9.8. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
          9.9. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
          9.10. North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
          9.11. Key Trends

    10. Europe Pharmaceutical Continuous Manufacturing Technology Market Analysis
          10.1. Key Findings
          10.2. Europe Pharmaceutical Continuous Manufacturing Technology Market Overview
          10.3. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
          10.4. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
          10.5. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
          10.6. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
          10.7. Europe Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
          10.8. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
          10.9. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
          10.10. Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
          10.11. Key Trends

    11. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Analysis
          11.1. Key Findings      
          11.2. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Overview
          11.3. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
          11.4. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
          11.5. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
          11.6. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
          11.7. Asia Pacific Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
          11.8. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
          11.9. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
          11.10. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
          11.11. Key Trends

    12. Latin America Pharmaceutical Continuous Manufacturing Technology Market Analysis
          12.1. Key Findings
          12.2. Latin America Pharmaceutical Continuous Manufacturing Technology Market Overview
          12.3. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
          12.4. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
          12.5. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
          12.6. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
          12.7. Latin America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
          12.8. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
          12.9. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
          12.10. Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis

    13. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Analysis
          13.1. Key Findings
          13.2. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Overview
          13.3. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
          13.4. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
          13.5. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application      
          13.6. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
          13.7. Middle East & Africa Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user      
          13.8. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
          13.9. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
          13.10. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis

    14. Competition Landscape
          14.1. Competition Matrix
          14.2. Company Profiles
                  14.2.1. Siemens AG 
                            14.2.1.1. Company Details
                            14.2.1.2. Business Overview
                            14.2.1.3. Financial Overview
                            14.2.1.4. Strategic Overview
                            14.2.1.5. SWOT Analysis
                  14.2.2. GEA Group 
                            14.2.2.1. Company Details
                            14.2.2.2. Business Overview
                            14.2.2.3. Financial Overview
                            14.2.2.4. Strategic Overview
                            14.2.2.5. SWOT Analysis
                  14.2.3. SK biotek Co., Ltd. 
                            14.2.3.1. Company Details
                            14.2.3.2. Business Overview
                            14.2.3.3. Financial Overview
                            14.2.3.4. Strategic Overview
                            14.2.3.5. SWOT Analysis
                  14.2.4. CONTINUUS Pharmaceuticals 
                            14.2.4.1. Company Details
                            14.2.4.2. Business Overview
                            14.2.4.3. Financial Overview
                            14.2.4.4. Strategic Overview
                            14.2.4.5. SWOT Analysis
                  14.2.5. Gebrüder Lödige Maschinenbau GmbH 
                            14.2.5.1. Company Details
                            14.2.5.2. Business Overview
                            14.2.5.3. Financial Overview
                            14.2.5.4. Strategic Overview
                            14.2.5.5. SWOT Analysis
                  14.2.6. Glatt GmbH 
                            14.2.6.1. Company Details
                            14.2.6.2. Business Overview
                            14.2.6.3. Financial Overview
                            14.2.6.4. Strategic Overview
                            14.2.6.5. SWOT Analysis
                  14.2.7. KORSCH AG 
                            14.2.7.1. Company Details
                            14.2.7.2. Business Overview
                            14.2.7.3. Financial Overview
                            14.2.7.4. Strategic Overview
                            14.2.7.5. SWOT Analysis
                  14.2.8. Scott Equipment Company 
                            14.2.8.1. Company Details
                            14.2.8.2. Business Overview
                            14.2.8.3. Financial Overview
                            14.2.8.4. Strategic Overview
                            14.2.8.5. SWOT Analysis
                  14.2.9. Thermo Fisher Scientific, Inc. 
                            14.2.9.1. Company Details
                            14.2.9.2. Business Overview
                            14.2.9.3. Financial Overview
                            14.2.9.4. Strategic Overview
                            14.2.9.5. SWOT Analysis
                  14.2.10. L.B. Bohle Maschinen + Verfahren Gmbh 
                            14.2.10.1. Company Details
                            14.2.10.2. Business Overview
                            14.2.10.3. Financial Overview
                            14.2.10.4. Strategic Overview
                            14.2.10.5. SWOT Analysis
                  14.2.11. Munson Machinery Company 
                            14.2.11.1. Company Details
                            14.2.11.2. Business Overview
                            14.2.11.3. Financial Overview
                            14.2.11.4. Strategic Overview
                            14.2.11.5. SWOT Analysis

    List of Tables

    TABLE 1 Revenue Share by Application
    TABLE 2 Revenue Share by End-user
    TABLE 3 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    TABLE 4 Global Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 5 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 6 Global Pharmaceutical Continuous Manufacturing Technology Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
    TABLE 7 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    TABLE 8 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    TABLE 9 North America Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 10 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 11 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    TABLE 12 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    TABLE 13 Europe Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 14 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 15 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    TABLE 16 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    TABLE 17 Asia Pacific Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 18 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 19 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    TABLE 20 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    TABLE 21 Latin America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user, 2015–2025
    TABLE 22 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 23 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    TABLE 24 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    TABLE 25 Middle East & Africa Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
    TABLE 26 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025

     

    List of Figures

    FIG. 1 Global Market Size (US$ Mn), by Application, 2016
    FIG. 2 Global Market Size (US$ Mn), by End-users, 2016
    FIG. 3 Key Trends in Continuous Manufacturing Technology
    FIG. 4 Global Market share, by Region, 2016
    FIG. 5 Key Industry Developments
    FIG. 6 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, 2015–2025
    FIG. 7 Market Value Share, by End-user (2016)
    FIG. 8 Market Value Share, by Application (2016)
    FIG. 9 Market Value Share, by Region (2016)
    FIG. 10 Addressable Pharmaceutical Manufacturing Market
    FIG. 11 Global API Manufacturing Technology Suppliers Market Share Analysis, by Company, 2016
    FIG. 12 Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
    FIG. 13 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Active Pharmaceutical Ingredients (API), 2015–2025
    FIG. 14 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Biologics, 2015–2025
    FIG. 15 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Dry Powder, 2015–2025
    FIG. 16 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2015–2025
    FIG. 17 Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2015–2025
    FIG. 18 Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 19 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pharmaceutical Companies, 2015–2025
    FIG. 20 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contract Manufacturing Organizations, 2015–2025
    FIG. 21 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
    FIG. 22 Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user,2017–2025
    FIG. 23 Global Market Scenario, by country
    FIG. 24 Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Region, 2016 and 2025
    FIG. 25 Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Region, 2017–2025 
    FIG. 26 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    FIG. 27 North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017–2025
    FIG. 28 North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
    FIG. 29 North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
    FIG. 30 North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 31 North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2017–2025
    FIG. 32 North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 33 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    FIG. 34 Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017–2025
    FIG. 35 Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
    FIG. 36 Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
    FIG. 37 Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 38 Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2015–2025
    FIG. 39 Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2015–2025
    FIG. 40 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    FIG. 41 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017–2025
    FIG. 42 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
    FIG. 43 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
    FIG. 44 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 45 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2015–2025
    FIG. 46 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2015–2025
    FIG. 47 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    FIG. 48 Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017–2025
    FIG. 49 Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
    FIG. 50 Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
    FIG. 51 Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 52 Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2017–2025
    FIG. 53 Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 54 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    FIG. 55 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017–2025
    FIG. 56 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
    FIG. 57 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
    FIG. 58 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
    FIG. 59 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2017–2025
    FIG. 60 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2017–2025
    FIG. 61 Siemens AG Breakdown of Net Sales, by Business Segment, 2016
    FIG. 62 Siemens AG Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
    FIG. 63 GEA Breakdown of Net Sales, by Business Segment, 2016
    FIG. 64 GEA Revenue for (US$ Bn) and Y-o-Y Growth (%), 2014–2016
    FIG. 65 SK biotek co. ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2016
    FIG. 66 Thermo Fischer Scientific, Inc Breakdown of Net Sales, by Region, 2016
    FIG. 67 Thermo Fischer Scientific, Inc Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016

     

Copyright © Transparency Market Research, Inc. All Rights reserved